Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 554)
Posted On: 09/25/2025 5:20:06 AM
Post# of 157264
Posted By: brentie

We get a brief mention...

7. Clinical Trials to Overcome Drug Resistance in Triple-Negative Breast Cancer
CXCR4-targeted agents are moved through translational pathways, with balixafortide and leronlimab making initial progress in TNBC [129]. The future lies in exploration involving combinations, patient stratification, and immunomodulatory combinations [130].

https://www.mdpi.com/2073-4409/14/18/1482













(7)
(0)








  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site